MarketCapTrends
BIIB

Biogen Inc. (BIIB)

NASDAQ · Healthcare

Biogen Inc. annual/quarterly long term debt history from 2010 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.

  • Biogen Inc. long term debt for the quarter ending December 31, 2025 were 6.29B, a 38.26% increase year-over-year.
  • Biogen Inc. long term debt for 2025 were 6.29B, a 38.26% increase from 2024.
  • Biogen Inc. long term debt for 2024 were 4.55B, a 33.01% decrease from 2023.
  • Biogen Inc. long term debt for 2023 were 6.79B, a 8.08% increase from 2022.
  • Biogen Inc. long term debt for 2022 were 6.28B.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Biogen Inc. Annual Long Term Debt (Millions of US $)
2025$6,287
2024$4,547
2023$6,788
2022$6,281
2021$6,274
2020$7,426
2019$4,459
2018$5,937
2017$5,935
2016$6,513
2015$6,522
2014$580
2013$592
2012$687
2011$1,024
Biogen Inc. Quarterly Long Term Debt (Millions of US $)
2025-12-31$6,287
2024-12-31$4,547
2023-12-31$6,788
2022-12-31$6,281
2021-12-31$6,274
2020-12-31$7,426
2019-12-31$4,459
2018-12-31$5,937
2017-12-31$5,935
2016-12-31$6,513
2015-12-31$6,522
2014-12-31$580
2013-12-31$592
2012-12-31$687
2011-12-31$1,024
2010-12-31$1,035

Biogen Inc. Long Term Debt — FAQ

Biogen Inc. (BIIB) long term debt over the last 19 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see BIIB's long term debt history?

The chart and table above show Biogen Inc.'s long term debt by year and by quarter, including the growth rate.